Per the brand, ProstaVitalis is built around three stated mechanisms, each targeted by a different group of ingredients within the 24-item formula.
Saw palmetto, plant sterols, and pygeum africanum are the three ingredients positioned here. Saw palmetto is one of the most-studied botanicals for prostate and urinary symptoms, but the evidence is genuinely mixed: a large NIH-funded randomized trial, even at triple the standard dose, found saw palmetto performed no better than placebo for BPH symptoms, while other trials (including a 2013 pilot study) reported improvement. The brand's claim that saw palmetto's DHT-inhibiting effect is "confirmed" by "over 20 clinical trials" overstates how consistent that evidence base actually is.
Pygeum africanum fares better: a Cochrane systematic review and a meta-analysis in the American Journal of Medicine both found it associated with modest improvement in urinary symptoms and flow measures versus placebo, at doses in the range this product uses (100mg, within the typical 75-200mg/day studied range).
Plant sterols (beta-sitosterol preparations) have Cochrane-reviewed evidence for improved urine flow and reduced residual urine volume, pooled across several hundred men — though typical studied doses run 60-130mg/day, lower than the 300mg "Plant Sterol Complex" figure here, and since the complex isn't confirmed to be pure beta-sitosterol, a direct dose comparison isn't fully possible.
Stinging nettle, cat's claw, and an amino acid blend (L-Glutamic Acid, L-Alanine, L-Glycine, amount not disclosed) are positioned for bladder control support. These have thinner individual research specifically for this purpose compared to the prostate-focused ingredients above.
Selenium, zinc, vitamin E, and a triple mushroom complex (Maitake, Reishi, Shiitake) round out the formula. Worth a direct correction here: the brand cites the SELECT trial (roughly 35,000 men) in connection with "long-term prostate health." That trial actually tested selenium and vitamin E for prostate cancer prevention, found no reduction in prostate cancer risk from selenium, and was stopped early in part over a signal of increased prostate cancer risk tied to vitamin E. Citing SELECT as support for a prostate-health benefit doesn't reflect what that trial actually found.
A 2014 randomized, double-blind, placebo-controlled trial did find pumpkin seed extract associated with BPH symptom improvement over 12 weeks, consistent with the brand's citation. But the amount of pumpkin seed in this specific "Proprietary Blend" isn't disclosed, so a dose comparison against that research isn't possible.
Pygeum and beta-sitosterol preparations have real research behind them for urinary symptoms. Saw palmetto's DHT-specific claim and the SELECT trial citation go further than the underlying research supports. None of this research is a substitute for a doctor's evaluation of prostate or urinary symptoms, and none of it constitutes a finished-product trial on ProstaVitalis itself.